SAN FRANCISCO — Two executives from Done Global, a San Francisco-based telehealth provider, were sentenced to prison for their roles in a scheme involving amphetamine/dextroamphetamine salts, commonly known as Adderall, the Justice Department said.

The department stated the alleged scheme generated approximately $90 million. Done Global operates as a telehealth company based in San Francisco. The sentencing marks a legal conclusion to the federal investigation into the distribution practices. No further details on the specific sentences or the identities of the executives were immediately available in the department's statement. The case highlights ongoing federal scrutiny of telehealth prescribing practices. The department continues to pursue cases involving the improper distribution of controlled substances. Industry observers note the significance of the judgment for the telehealth sector. The outcome serves as a warning to other providers in the space. Legal experts suggest this could lead to tighter regulations. The Justice Department emphasized its commitment to holding violators accountable. The investigation into Done Global's operations spanned several months. Prosecutors presented evidence regarding the volume of prescriptions issued. The defense argued that the prescriptions were medically justified. The court rejected these arguments during the sentencing phase. The executives will begin serving their terms shortly. The case remains one of the largest of its kind. The department plans to release further documentation soon.